Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease | Zendy

Nisha Bansal | Zendy; Adam A. Szpiro | Zendy; Kristi Reynolds | Zendy; David H. Smith | Zendy; David J. Magid | Zendy; Jerry H. Gurwitz | Zendy; Frederick A. Masoudi | Zendy; Robert T. Greenlee | Zendy; Grace H. Tabada | Zendy; Sue Hee Sung | Zendy; Ashveena Dighe | Zendy; Alan S. Go | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease

Author(s) -

Nisha Bansal,

Adam A. Szpiro,

Kristi Reynolds,

David H. Smith,

David J. Magid,

Jerry H. Gurwitz,

Frederick A. Masoudi,

Robert T. Greenlee,

Grace H. Tabada,

Sue Hee Sung,

Ashveena Dighe,

Alan S. Go

Publication year - 2018

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2017.8462

Subject(s) - medicine , kidney disease , heart failure , ejection fraction , sudden cardiac death , population , cardiology , renal function , implantable cardioverter defibrillator , cohort , intensive care medicine , environmental health

Chronic kidney disease (CKD) is common in adults with heart failure and is associated with an increased risk of sudden cardiac death. Randomized trials of participants without CKD have demonstrated that implantable cardioverter defibrillators (ICDs) decrease the risk of arrhythmic death in selected patients with reduced left ventricular ejection fraction (LVEF) heart failure. However, whether ICDs improve clinical outcomes in patients with CKD is not well elucidated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research